United Therapeutics (UTHR) announced that ten posters and presentations across its commercial and development portfolio will be presented at ...

“The past year has been transformational for Tenax Therapeutics ... first-in-class K-ATP activator/calcium sensitizer currently being evaluated to treat pulmonary hypertension (PH) with heart ...

AGOURA HILLS, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), ”), a leader in ...

PLANO, Texas & BALTIMORE, March 25, 2025--(BUSINESS WIRE)--Secretome Therapeutics ... of the first patient in its Phase 1 clinical trial evaluating STM-01 as a treatment for heart failure with ...

Secretome Therapeutics ... (nCPC), today announced dosing of the first patient in its Phase 1 clinical trial evaluating STM-01 as a treatment for heart failure with preserved ejection fraction ...

MANILA, Philippines – First Gen Corp. said its net income fell by 12 percent in 2024 as it suffered lower revenues and incurred higher expenses to sustain operations. In a disclosure on Friday ...

HIGH POINT, N.C., March 20, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin, a potential ...

Former Premier League defender Richard Dunne has urged Aston Villa to sign Marcus Rashford on a permanent deal this summer - insisting the Manchester United ... squad for the first time since ...

Plus Therapeutics shares are trading higher by 244% during Thursday's session. The company announced that the FDA accepted the name REYOBIQ for the company's lead asset. The ‘Trade of the Day ...

SEATTLE, March 20, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq ... and financial results for the fourth quarter and full-year 2024. The webcast will be available at the investor ...